Browse > Article
http://dx.doi.org/10.5223/pghn.2022.25.6.473

Use of Dual-Energy X-ray Absorptiometry in Children with Inflammatory Bowel Disease: A Large Single Centre Study  

Jois, Asha (Department of Gastroenterology and Clinical Nutrition, Royal Children's Hospital)
Perera, Sajini (General Medicine, Royal Children's Hospital)
Simm, Peter (Department of Endocrinology, Royal Children's Hospital)
Alex, George (Department of Gastroenterology and Clinical Nutrition, Royal Children's Hospital)
Publication Information
Pediatric Gastroenterology, Hepatology & Nutrition / v.25, no.6, 2022 , pp. 473-480 More about this Journal
Abstract
Purpose: Low bone mineral density (BMD) is a complication in children with inflammatory bowel disease (IBD). There are limited data evaluating dual-energy x-ray absorptiometry (DXA) as a screening tool for low BMD in children with IBD. We performed a single site retrospective analysis of DXA use. Methods: Children aged 5-18 years with IBD diagnosed between 2013 to 2017 at the Royal Children's Hospital, Australia, were included. Patient demographics, measures of disease activity, DXA scores, and factors related to BMD were collected. Results: Over a median follow up of 5.1 (4-6.4) years, 72/239 (30.1%) children underwent DXA, and 28/239 (11.7%) children had a second DXA. Our DXA practice differed to consensus guidelines regarding initial screening based on height and/or body mass index (BMI) z-score (8/17 [47.1%]), and repeat surveillance (13/42 [31.0%]). Children had a median lumbar spine (LS) z-score -0.80 (-1.65-0.075). Children with LS z-score≤-2.0 (n=14) had lower weight (6.57 [1.78-23.7] vs. 51.1 [26.5-68.7], p=0.0002) and height centiles (3.62 [1.17-17.1] vs. 42 [16.9-67.1], p=0.0001), and higher faecal calprotectin (FCP) (3041 [1182-4192] vs. 585 [139-2419], p=0.009) compared to children with LS z-score>-2.0. No fractures were reported. Of 28 children who underwent a second DXA 1.6 (1.1-2.2) years following initial DXA, no significant change in z-scores occurred. Conclusion: Children with IBD had low BMD. In addition to height centile and weight centile, FCP was associated with lower BMD, and should be considered in DXA screening guidelines. Greater clinician awareness of DXA consensus guidelines is required. Future prospective studies are required.
Keywords
Inflammatory bowel disease; Child; Absorptiometry, photon;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Pappa H, Thayu M, Sylvester F, Leonard M, Zemel B, Gordon C. Skeletal health of children and adolescents with inflammatory bowel disease [Erratum in: J Pediatr Gastroenterol Nutr 2012;54:571]. J Pediatr Gastroenterol Nutr 2011;53:11-25.   DOI
2 Harpavat M, Greenspan SL, O'Brien C, Chang CC, Bowen A, Keljo DJ. Altered bone mass in children at diagnosis of Crohn disease: a pilot study. J Pediatr Gastroenterol Nutr 2005;40:295-300.   DOI
3 Hill RJ, Brookes DS, Lewindon PJ, Withers GD, Ee LC, Connor FL, et al. Bone health in children with inflammatory bowel disease: adjusting for bone age. J Pediatr Gastroenterol Nutr 2009;48:538-43.   DOI
4 Jones AR, Zacharin MR, Cameron FJ, Simm PJ. Bone density assessment in a tertiary paediatric centre over 13 years: Referral patterns and limitations. J Paediatr Child Health 2015;51:608-13.   DOI
5 Paganelli M, Albanese C, Borrelli O, Civitelli F, Canitano N, Viola F, et al. Inflammation is the main determinant of low bone mineral density in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2007;13:416-23.   DOI
6 Walsham NE, Sherwood RA. Fecal calprotectin in inflammatory bowel disease. Clin Exp Gastroenterol 2016.9:21-9.
7 Gupta A, Paski S, Issenman R, Webber C. Lumbar spine bone mineral density at diagnosis and during follow-up in children with IBD. J Clin Densitom 2004;7:290-5.   DOI
8 Weber DR, Boyce A, Gordon C, Hogler W, Kecskemethy HH, Misra M, et al. The utility of DXA assessment at the forearm, proximal femur, and lateral distal femur, and vertebral fracture assessment in the pediatric population: 2019 ISCD Official Position. J Clin Densitom 2019;22:567-89.   DOI
9 Gokhale R, Favus MJ, Karrison T, Sutton MM, Rich B, Kirschner BS. Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology 1998;114:902-11.   DOI
10 Sigurdsson GV, Schmidt S, Mellstrom D, Ohlsson C, Kindblom JM, Lorentzon M, et al. Bone mass development from childhood into young adulthood in patients with childhood-onset inflammatory bowel disease. Inflamm Bowel Dis 2017;23:2215-26.   DOI
11 Guz-Mark A, Rinawi F, Egotubov O, Shimon I, Shamir R, Assa A. Pediatric-onset inflammatory bowel disease poses risk for low bone mineral density at early adulthood. Dig Liver Dis 2017;49:639-42.   DOI
12 Zemel BS, Leonard MB, Kelly A, Lappe JM, Gilsanz V, Oberfield S, et al. Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab 2010;95:1265-73.   DOI
13 Kappelman MD, Galanko JA, Porter CQ, Sandler RS. Risk of diagnosed fractures in children with inflammatory bowel diseases. Inflamm Bowel Dis 2011;17:1125-30.   DOI
14 Ronel N, Tzion RL, Orlanski-Meyer E, Shteyer E, Guz-Mark A, Assa A, et al. Clinical criteria can identify children with osteopenia in newly diagnosed Crohn disease. J Pediatr Gastroenterol Nutr 2021;72:270-5.   DOI
15 Schmidt S, Mellstrom D, Norjavaara E, Sundh V, Saalman R. Longitudinal assessment of bone mineral density in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2012;55:511-8.   DOI
16 Bernstein CN, Leslie WD. The pathophysiology of bone disease in gastrointestinal disease. Eur J Gastroenterol Hepatol 2003;15:857-64.   DOI
17 Clark EM, Ness AR, Bishop NJ, Tobias JH. Association between bone mass and fractures in children: a prospective cohort study. J Bone Miner Res 2006;21:1489-95.   DOI
18 Laakso S, Valta H, Verkasalo M, Toiviainen-Salo S, Makitie O. Compromised peak bone mass in patients with inflammatory bowel disease--a prospective study. J Pediatr 2014;164:1436-43.e1.   DOI
19 Baxter-Jones AD, Faulkner RA, Forwood MR, Mirwald RL, Bailey DA. Bone mineral accrual from 8 to 30 years of age: an estimation of peak bone mass. J Bone Miner Res 2011;26:1729-39.   DOI
20 Wahner HW, Dunn WL, Brown ML, Morin RL, Riggs BL. Comparison of dual-energy x-ray absorptiometry and dual photon absorptiometry for bone mineral measurements of the lumbar spine. Mayo Clin Proc 1988;63:1075-84.   DOI
21 Pichler J, Hanslik A, Huber WD, Aufricht C, Bidmon-Fliegenschnee B. Paediatric patients with inflammatory bowel disease who received infliximab experienced improved growth and bone health. Acta Paediatr 2014;103:e69-75.   DOI
22 Boot AM, Bouquet J, Krenning EP, de Muinck Keizer-Schrama SM. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut 1998;42:188-94.   DOI
23 Sylvester FA, Wyzga N, Hyams JS, Davis PM, Lerer T, Vance K, et al. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease. Inflamm Bowel Dis 2007;13:42-50.   DOI
24 Rozes S, Guilmin-Crepon S, Alison M, Thomas E, Hugot JP, Viala J, et al. Bone health in pediatric patients with Crohn disease. J Pediatr Gastroenterol Nutr 2021.73:231-5.   DOI
25 Schmidt S, Mellstrom D, Norjavaara E, Sundh SV, Saalman R. Low bone mineral density in children and adolescents with inflammatory bowel disease: a population-based study from Western Sweden. Inflamm Bowel Dis 2009;15:1844-50.   DOI